Navigation Links
PrimeGen Biotech Reaffirms its Commitment to Stem Cell Science - Opens New 10,000 SQ. FT. Research Facility and HQ
Date:6/23/2015

SANTA ANA, Calif., June 23, 2015 /PRNewswire/ -- PrimeGen Biotech, a pioneer in the research and discovery of practical therapeutic uses for stem cells, today announced the opening of its new 10,000 square-foot research facility located in Santa Ana, California. Founded by co-founder of AST Computers and former CEO of SRS Labs, Thomas C.K. Yuen plans to utilize PrimeGen's new research facility and his expertise in marketing cutting-edge technologies to lead PrimeGen's team of research scientists in the discovery of new breakthroughs in stem cell science, and bringing advanced treatments of degenerative and aging related diseases to market.

The company's ongoing research has shown promising signs that stem cells derived from various tissues in the body may serve specialized medical purposes; PrimeGen's new facility was designed to give its research team the space and tools necessary to delve deeper into the characterization of stem cells and their respective therapeutic value, while complying with FDA's Current Good Manufacturing Practice (CGMP) regulations, readying for the translational phase of their stem cell therapeutic objectives.

The new facility features five main laboratories dedicated to:

  • Tissue Processing
  • Cell Culture Research and Development
  • Molecular Biology
  • Flow Cytometry
  • Histology

"Stem cell research has come a long way since we started PrimeGen 13 years ago, and so have the techniques and technology requirements associated with the science," said Tom Yuen, CEO of PrimeGen Biotech, LLC. "Our new facility was custom designed and built featuring advanced laboratories filled with the latest equipment; allowing our research team to continue pioneering new uses for stem cells as regenerative medicine."

To learn more about PrimeGen Biotech and its research, please visit www.primegenbiotech.com.

About PrimeGen Biotech LLC:

Founded in 2002, PrimeGen Biotech is a privately-held research firm dedicated to discovering the best possible applications for stem cell therapies and translating its research into effective therapeutic applications. PrimeGen Biotech is located in Santa Ana, California and operates in a 10,000 sq ft facility.  The newly renovated facility consists of modern laboratories capable of cell processing, cell culture, molecular biology, flow cytometry, and histology.  The laboratories are designed specifically to meet the requirements of our unique research approaches. The PrimeGen team includes research scientists and specialists with decades' experience researching adult stem cells.

PrimeGen Media Contact:
Michael Farino
New Era Communications Services, LLC
949-346-1984
primegen@newerapr.com

Logo - http://photos.prnewswire.com/prnh/20150618/224024LOGO

 


'/>"/>
SOURCE PrimeGen Biotech
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Ceres Continues Realignment Toward Food and Feed Markets and Biotech Traits
2. Harwood Feffer LLP Announces Investigation of Avalanche Biotechnologies, Inc.
3. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avalanche Biotechnologies, Inc. - AAVL
4. Global biotech industry continues to sizzle as market capitalization surpasses US$1 trillion
5. Osprey Biotechnics Named A 2015 Safer Choice Partner Of The Year Award Winner
6. UMBC Biotechnology Graduate Programs’ Virtual Info Session, June 24, 2015
7. Clear Guide Medical Receives Designation Of Qualified Maryland Biotechnology Company
8. Goodwin Biotechnology and Aspyrian Therapeutics Collaborate on the Successful GMP Manufacturing and IND Submission for a Novel Antibody Drug Conjugate (ADC) Platform
9. Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024
10. Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies
11. PDS Biotechnology reports positive Phase I clinical trial results in proprietary HPV-Cancer Immunotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2018)... ... August 21, 2018 , ... ... specializing in medical device compliance and commercialization, has just released a new ... Written and presented by Dr. Mario Kossmann, ESEP at the 28th Annual ...
(Date:8/17/2018)... ... August 16, 2018 , ... KCAS Bioanalytical ... announce the expansion of their team. Dr. Dawn Dufield, Ph.D., joins KCAS as ... large molecule LC-MS/MS group that will specialize in developing quantitative LC-MS/MS assays for ...
(Date:8/14/2018)... ... 13, 2018 , ... Labconco Corporation manufactures laboratory equipment, specializing ... addition, Labconco produces other lab equipment, such as glassware washers and freeze dryers. ... consistency in design and manufacturing. , Through this webinar, which is sponsored ...
(Date:8/11/2018)... ... ... Researchers performing pressurized NMR or EPR experiments face a danger of the tube ... & EPR by Wilmad-LabGlass – SP Scienceware shields researchers from flying debris and ... significantly grown in popularity over the last several years. As a result, the risk ...
Breaking Biology Technology:
(Date:8/23/2018)... , ... August 21, 2018 , ... ... genomes of diverse cell types and species for the robust functional interrogation of ... for the development of T-cell based immunotherapies, the study of the autoimmunity, the ...
(Date:8/21/2018)... ... August 20, 2018 , ... ... are many challenges to consider. Designers must ensure what is designed can be ... will explore some best practices in flow path design with specific focus on ...
(Date:8/17/2018)... DENVILLE, N.J. and LIEGE, Belgium (PRWEB) , ... ... ... Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service ... epigenetics services including a number of targeted DNA methylation assays using pyrosequencing ...
Breaking Biology News(10 mins):